Outcome measures included plasma lipids, amino acids, glucose, serum FGF21, and other biomarkers related to energy metabolism, including adipose tissue gene expression and plasma SCD activity indices in healthy women with overweight and obesity. This evidence concerns the gene FGF21 and obesity disorder.